A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19

(JOURNAL OF CRITICAL CARE)

A Trial of Lopinavir – Ritonavir in Adults Hospitalized with Severe COVID-19

(NEJM)

Are there any evidence-based ways of assessing dyspnoea (breathlessness) by telephone or video? -Trish Greenhalgh, Koot Kotze and Helene-Mari Van Der

(CEBM RESEARCH)

Assessment of Evidence for COVID-19 – Related Treatments

(ASHP)

COVID-19: consider cytokine storm syndromes and immunosuppression

(LANCET)

COVID-19 y Tabaco

Constantine I. Vardavas; KAterina Nikitara. Covid-19 and smoking: A systematic review of the evidence. Tobacco induced diseases. 2020; 18 (March) 20

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open- label non-randomized clinical trial

Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. International Journal of Antimicrobial Agents – In Press 17 March 2020

On the use of corticosteroids for 2019-nCoV pneumonia

(LANCET)

Tormenta de citoquinas e inmunosupresión

(INTRAMED)

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A Review

(JAMA)

Temporal dynamics in viral shedding and transmissibility of COVID-19

(Nature Medicine)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

(Lancet)

The Untold Toll — The Pandemic’s Effects on Patients without COVID-19

(NEJM)